Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01729286 · ClinicalTrials.gov registry record · NA
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
A NA study, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT01729286 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 92 participants.
The verdict
NCT01729286, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The objective of this study is to compare the effectiveness of PriMatrix Moist Wound Therapy (MWT) with Standard of Care MWT for the treatment of chronic diabetic foot ulcers in subjects with diabetes mellitus and without significantly compromised arterial circulation.
Interventions
- DEVICE PriMatrix Moist Wound Therapy
- OTHER Standard of Care Moist Wound Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01729286
The ClinicalTrials.gov registry entry for NCT01729286 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PriMatrix Moist Wound Therapy is the first listed.
NCT01729286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01729286 about?
NCT01729286 is a clinical study titled "Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix". The objective of this study is to compare the effectiveness of PriMatrix Moist Wound Therapy (MWT) with Standard of Care MWT for the treatment of chronic diabetic foot ulcers in subjects with diabetes mellitus and without significantly compromised arterial circulation.
What is the current status of trial NCT01729286?
This trial is currently terminated. It is a NA study. The enrollment target is 92 participants. The study started on 2012-09. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01729286?
The interventions under investigation include: PriMatrix Moist Wound Therapy (DEVICE), Standard of Care Moist Wound Therapy (OTHER).
Who is sponsoring clinical trial NCT01729286?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.